查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1689881

聚乙烯吡咯烷酮：市場佔有率分析、產業趨勢與統計、成長預測（2025-2030 年）

Polyvinylpyrrolidone - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計預測期內聚乙烯吡咯烷酮市場複合年成長率將超過 8%。

聚乙烯吡咯烷酮-市場-IMG1

在 COVID-19 疫情期間，由於終端用戶應用需求減少，聚乙烯吡咯烷酮的需求下降。全球長期停工導致建築業勞動力短缺和供應鏈中斷，影響了建築業關鍵應用——對黏合劑的需求。此外，疫情期間，對人員流動的嚴格限制導致包裝食品和速食食品、化妝品和個人保健產品的零售額放緩。另一方面，由於製藥業的持續成長，醫藥領域對聚乙烯吡咯烷酮的需求略有改善。不過，現在製造業已完全恢復到疫情前的活動水平，預計未來幾年對聚乙烯吡咯烷酮的需求將穩定成長。

主要亮點

  • 聚乙烯吡咯烷酮廣泛用於製藥工業，作為錠劑生產中的粘合劑。隨著疫情過後世界主要經濟體紛紛加大對製藥業的投入，預計該領域的研究市場需求將出現強勁成長。
  • 此外，住宅和商業建築需求的不斷成長導致全球建設活動增加，預計這將進一步推動對聚乙烯吡咯烷酮的需求。
  • 然而，所研究的市場可能會受到在各種應用中取代聚乙烯吡咯烷酮的替代品的影響。
  • 另一方面，個人護理和化妝品行業不斷擴大的應用前景或為研究市場提供未來的成長機會。
  • 亞太地區佔據市場主導地位，預計在預測期內將繼續保持主導地位。

聚乙烯吡咯烷酮市場趨勢

製藥業需求不斷成長

  • 聚乙烯吡咯烷酮（PVP）具有優良的溶解性、增溶性、結合強度、絡合強度等，在醫藥衛生領域中用作粘合劑、被覆劑、助溶劑、消毒劑、增溶劑、緩釋劑、膠囊殼、分散穩定劑等。
  • 製藥業和藥品可能是最早和最知名地受益於 PVP 的行業，因為 PVP 具有優異的生物相容性，並且能夠與多種活性物質形成穩定的締合物和複合物。
  • 中國、印度、美國和德國擁有世界上最大的製藥產業。據估計，全球約40%的原料藥由中國製造商生產。此外，中國和印度供應了美國進口的75%至80%的原料藥。降低成本和放寬環境法規的願望正在推動中國和印度製藥業的發展。
  • 據Astra Zeneca稱，預計2024年北美的醫藥銷售額將達到6,330億美元，其次是歐盟（不包括英國），銷售額為2,870億美元，東南亞和東亞為2,320億美元。
  • 製藥業是美國的主要產業之一，也是美國研發最密集的產業之一。據Astra Zeneca稱，美國製藥業是全球最大的製藥業，2022年佔全球醫藥銷售額的49.8%，銷售額達6,050億美元。
  • 美國人口的成長和老化正在刺激製藥業的擴張。此外，美國口中有 15% 年齡在 65 歲或以上，預計到 2023 年這一比例還會增加。
  • 根據英國製藥工業協會（ABPI）估計，英國製藥業年營業額約502.1億歐元（約583.6億美元）。市場的主要企業包括GlaxoSmithKline Plc和Astra Zeneca。此外，該國也是向世界各地患者出口救命藥品的主要國家之一。
  • 2022年，英國向全球出口了價值254億歐元（295.2億美元）的醫藥和醫療產品，進口了價值約308億歐元的產品，導致虧損約54億歐元（62.8億美元）。
  • 預計預測期內製藥業的這些趨勢將增加所研究市場的需求。

亞太地區佔市場主導地位

  • 預計預測期內聚乙烯吡咯烷酮市場將由亞太地區主導。由於製藥業的發展，中國、印度和日本等國家對聚乙烯吡咯烷酮的需求正在增加。
  • 在我國，聚乙烯吡咯烷酮（PVP）被廣泛應用於製藥工業作為安全的黏合劑和血漿擴容劑。中國製藥業是世界上最大的製藥業之一。該國生產學名藥、治療藥物、原料藥和草藥。
  • 日本註冊的藥品90%以上都是學名藥。為發展醫療保健產業，政府實施了「健康中國2030」策略，目標是到2030年將市場規模擴大到2.4兆美元。
  • 根據Invest India的報告，預計2024年印度製藥業的市場規模將達到650億美元，到2030年將進一步達到1,300億美元。這有望增加藥品產量並滿足該國的市場需求。
  • 以產量計算，印度是世界第三大藥品生產國，以金額計算，印度是世界第十四大藥品生產國。印度製藥業對印度GDP的貢獻約2%，對商品出口總額的貢獻約8%。
  • 同時，根據印度品牌股權基金會的數據，預計到 2022 年印度外出用餐市場的價值將達到近 410 億美元。快餐店佔了很大的金額。從細分市場來看，與前一年同期比較，但非正規部門仍主導著餐飲業。
  • 食品業的收益正在大幅成長，研究表明，預計到 2025 年將成長到 11,631.9 億美元。此外，根據印度醫學研究理事會 (ICMAR) 的數據，印度冷凍食品市場預計在 2019 年至 2024 年間將成長 17%，這可能會刺激食品應用研究市場的需求。
  • 根據美國農業部（USDA）統計，日本食品業預計2022年食品產量將達1,900億美元，較2021年下降12.4%。不過，酒精飲料、軟性飲料、魚製品和其他健康食品類別的產量增加。
  • 為了促進化妝品產業的成長，東京化妝品工業協會、日本化妝品工業協會、西日本化妝品工業協會、中部化妝品工業協會於2023年4月合併成立日本化妝品工業協會。
  • 考慮到上述因素，預計預測期內該地區對聚乙烯吡咯烷酮的需求將會成長。

聚乙烯吡咯烷酮產業概況

聚乙烯吡咯烷酮市場本質上是整合的。前五大公司佔據了大部分市場佔有率。市場的主要企業包括BASF歐洲公司、亞什蘭、博愛新開源製藥有限公司、四川天華化工集團和錦華南航生命科學。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 驅動程式
    • 製藥業需求不斷成長
    • 擴大作為建設產業黏合劑的用途
  • 限制因素
    • 替代方案的可用性
  • 價值鏈分析
  • 波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章 市場區隔

  • 形式
    • 粉末
    • 液體
  • 應用
    • 藥品
    • 飲食
    • 化妝品
    • 膠水
    • 其他用途
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 義大利
      • 法國
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東和非洲地區

第6章 競爭格局

  • 併購、合資、合作、協議
  • 市場佔有率（%）分析
  • 主要企業策略
  • 公司簡介
    • Ashland
    • BASF SE
    • Boai NKY Pharmaceuticals Ltd.
    • Glide Chem Private Limited
    • Hangzhou Motto Science & Technology Co. Ltd.
    • JH Nanhang Life Sciences Co. Ltd.
    • Nippon Shokubai Co. Ltd.
    • Shanghai Qifuqing Material Technology Co. Ltd.
    • Shanghai Yuking Water Soluble Material Tech Co. Ltd.
    • Sichuan Tianhua Chemical Group Co. Ltd.
    • Thermo Fisher Scientific Inc.
    • Zhangzhou Huafu Chemical Co. Ltd.

第7章 市場機會與未來趨勢

  • 擴大個人護理和化妝品行業的應用範圍
  • 其他機會
簡介目錄
Product Code: 69095

The Polyvinylpyrrolidone Market is expected to register a CAGR of greater than 8% during the forecast period.

Polyvinylpyrrolidone - Market - IMG1

During the outbreak of the COVID-19 pandemic, demand for polyvinylpyrrolidone declined due to reduced demand from end-user applications. Prolonged lockdowns worldwide resulted in labor shortages and supply chain disruptions in the construction segment, affecting the demand for adhesives that find major applications in the segment. Furthermore, with strict restrictions on people's movement, retail sales for packaged and fast food, cosmetics, and personal care products slumped during the pandemic. On the flip side, the continued growth of the pharmaceutical industry slightly improved the demand for polyvinylpyrrolidone in pharmaceutical applications. However, with the manufacturing sector now fully restored to pre-pandemic levels of activity, demand for polyvinylpyrrolidone is anticipated to grow steadily during the next several years.

Key Highlights

  • Polyvinylpyrrolidone is extensively used in the pharmaceutical industry as a binder in the manufacturing of tablets. With major economies across the globe spending on developing the pharmaceutical industry in the aftermath of the pandemic, the demand for the studied market is projected to experience strong growth in the segment.
  • Furthermore, growing construction activities across the globe, in view of rising demand for residential and commercial construction, are anticipated to further boost demand for polyvinylpyrrolidone.
  • However, the studied market could likely be affected by the presence of substitute products that can potentially replace polyvinylpyrrolidone across various applications.
  • On the flip side, an increasing application scope in the personal care and cosmetics industry may present future growth opportunities for the studied market.
  • Asia-Pacific dominated the market and is expected to continue its dominance during the forecast period, major supported by the extensive growth of the pharmaceutical segment in the region.

Polyvinylpyrrolidone Market Trends

Rising Demand in the Pharmaceutical Industry

  • Polyvinylpyrrolidone or PVP can be used in medical and health fields as a binder, excipient, coating, bounded solution of an agent, cosolvent, sterilization disinfectant, solubilizer, sustained release agent, capsule shell, dispersion stabilizer, others due to its excellent solubility, solubilization property, bonding capacity, complexing power, and other functions.
  • The pharmaceutical industry and medicine are the earliest and probably the most well-known areas to have benefited from PVP due to its extraordinary biocompatibility and ability to create stable association compounds and complexes with various active substances.
  • China, India, the United States, and Germany are the largest pharmaceutical industries in the world. It is estimated that Chinese manufacturers make up around 40% of all the APIs used worldwide. Additionally, China and India are the sources of 75% to 80% of the APIs imported to the United States. The desire for cost savings and less stringent environmental regulations has been driving the pharmaceutical industries in China and India.
  • According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America holding the major share, followed by the European Union (excluding the United Kingdom) with USD 287 billion at the second position, then Southeast and East Asia expected to register USD 232 billion.
  • The pharmaceutical sector is one of the major industries in the United States and one of the country's most research and development-intensive industries. According to AstraZeneca, the pharmaceutical industry in the United States is the largest globally, accounting for 49.8% of global pharmaceutical sales in 2022, with sales amounting to USD 605 billion.
  • The United States' expanding and aging population is fuelling the expansion of the pharmaceutical industry. Moreover, 15% of the population in the United States is over 65, and this percentage is predicted to expand by 2023.
  • According to the Association of the British Pharmaceutical Industry (ABPI), the annual turnover of the United Kingdom's pharmaceutical industry is estimated at around EUR 50.21 billion (USD 58.36 billion). Some of the key players in the market include GlaxoSmithKline and AstraZeneca. Furthermore, the country is one of the major exporters of life-saving drugs to patients across the world.
  • In 2022, the United Kingdom exported EUR 25.4 billion (USD 29.52 billion) worth of pharmaceutical and medicinal products around the world and imported around EUR 30.8 billion worth of products, with the trade deficit standing at approximately EUR 5.4 billion (USD 6.28 billion).
  • Such trends in the pharmaceutical industry are anticipated to augment demand for the studied market during the forecast period.

Asia-Pacific Region to Dominate the Market

  • The Asia-Pacific region is expected to dominate the market for polyvinylpyrrolidone during the forecast period. In countries like China, India, and Japan, the demand for polyvinylpyrrolidone has been increasing in the region due to the growing pharmaceutical industry.
  • In China, polyvinylpyrrolidones (PVP) are widely adopted as a safe binder and blood plasma expander in the pharma industry. The pharmaceutical industry in China is one of the largest in the world. The country produces generics, therapeutic medicines, active pharmaceutical ingredients, and traditional Chinese medicine.
  • More than 90% of the drugs registered in the country are generic. The government has implemented the "Healthy China 2030" initiative for developing the healthcare industry, which aims for the market to reach a value of USD 2.4 trillion by 2030.
  • According to a report by Invest India, the pharmaceutical industry in India is anticipated to reach a market value of USD 65 billion by the year 2024, with further growth projected to reach USD 130 billion by 2030. This is anticipated to increase the production of pharmaceutical goods and, thereby, is likely to benefit the market demand in the country.
  • India ranks 3rd worldwide for production by volume and 14th by value. The Indian pharmaceutical sector contributes about 2% to India's GDP and around 8% to the country's total merchandise exports.
  • On the other hand, according to the India Brand Equity Foundation, the food service market in India was estimated to be nearly USD 41 billion in 2022. Quick-service restaurants accounted for a large value of the market. In terms of segments, the unorganized sector dominated the food service industry, even though the organized market has a significant year-on-year growth.
  • The revenue from the food industry has been growing significantly and is projected to grow to USD 1,163.19 billion in 2025, as per the study. Moreover, the Indian frozen food market is expected to grow by 17% from 2019 to 2024, according to the Indian Council of Medical Research (ICMAR), thereby potentially augmenting demand for the studied market in food applications.
  • According to the US Department of Agriculture (USDA), the Japanese food industry produced food valued at USD 190 billion in 2022, declining by 12.4% in comparison to 2021. However, an increase in production was seen in alcoholic beverages, soft drinks, fish products, and other health food categories.
  • To facilitate the growth of the cosmetic industry, the Japan Cosmetic Industry Association (JCIA) was established in April 2023 by integrating the Tokyo Cosmetic Industry Association, the Japan Cosmetic Industry Federation, the West Japan Cosmetic Industry Association, and the Chubu Cosmetic Industry Association.
  • Thus, the factors above indicate a growing demand for polyvinylpyrrolidone in the region during the forecast period.

Polyvinylpyrrolidone Industry Overview

The polyvinylpyrrolidone market is consolidated in nature. The top five players account for a major share of the market. Major companies in the market include BASF SE, Ashland, Boai NKY Pharmaceuticals Ltd., Sichuan Tianhua Chemical Group Co., Ltd., and JH Nanhang Life Sciences Co., Ltd, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Rising Demand in the Pharmaceutical Industry
    • 4.1.2 Growing Application as Adhesives in the Construction Industry
  • 4.2 Restraints
    • 4.2.1 Presence of Substitutes
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Form
    • 5.1.1 Powder
    • 5.1.2 Liquid
  • 5.2 Application
    • 5.2.1 Pharmaceutical
    • 5.2.2 Food and Beverage
    • 5.2.3 Cosmetics
    • 5.2.4 Adhesives
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%) Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Ashland
    • 6.4.2 BASF SE
    • 6.4.3 Boai NKY Pharmaceuticals Ltd.
    • 6.4.4 Glide Chem Private Limited
    • 6.4.5 Hangzhou Motto Science & Technology Co. Ltd.
    • 6.4.6 JH Nanhang Life Sciences Co. Ltd.
    • 6.4.7 Nippon Shokubai Co. Ltd.
    • 6.4.8 Shanghai Qifuqing Material Technology Co. Ltd.
    • 6.4.9 Shanghai Yuking Water Soluble Material Tech Co. Ltd.
    • 6.4.10 Sichuan Tianhua Chemical Group Co. Ltd.
    • 6.4.11 Thermo Fisher Scientific Inc.
    • 6.4.12 Zhangzhou Huafu Chemical Co. Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Increasing Application Scope in the Personal Care and Cosmetic Industry
  • 7.2 Other Opportunities